Abstract
ADAW talked to Neeraj Gandotra, M.D., chief medical officer of the Substance Abuse and Mental Health Services Administration (SAMHSA) last week about the connection between liberalized methadone take‐homes from opioid treatment programs (OTPs) and methadone overdoses (ODs). First, methadone OD deaths did not increase as a result of liberalized take‐homes, as reported by the Centers for Disease Control and Prevention (see No rise in methadone OD deaths with new take‐home rules, ADAW July 25; https://onlinelibrary.wiley.com/doi/10.1002/adaw.33506). But where did this information come from, and is there any information about increases in methadone nonfatal ODs, or methadone diversion, in the wake of the liberalized policy?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
